Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study
BMJ Paediatr Open. 2024 Sep 9;8(1):e002483. doi: 10.1136/bmjpo-2023-002483. ABSTRACT PURPOSE: Montelukast is used extensively in children and adolescents for allergic rhinitis and asthma. However, concerns …